| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $582K | -92.5% |
| R&D Expense | $65.4M | +68.7% |
| SG&A Expense | $30.2M | -13.3% |
| Operating Income | -$95.1M | -44.3% |
| Interest Expense | $263K | +0.0% |
| Net Income | -$91.8M | -37.0% |
| EPS (Basic) | -$2.31 | +38.1% |
| EPS (Diluted) | -$2.31 | +38.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $159.5M | — |
| Current Assets | $223.9M | -21.9% |
| Total Assets | $238.7M | -17.0% |
| Current Liabilities | $13.8M | +49.3% |
| Total Liabilities | $20.5M | +118.0% |
| Stockholders' Equity | $218.2M | -21.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.7M | -60.0% |
| Capital Expenditures | $11.1M | +1004.7% |
| Investing Cash Flow | -$169.4M | — |
| Financing Cash Flow | $10.3M | -96.6% |
| Free Cash Flow | -$72.8M | -84.1% |